Publikasi Scopus 926 artikel (Per 14 Maret 2022)

Wang G., Tanaka A., Zhao H., Jia J., Ma X., Harada K., Wang F.-S., Wei L., Wang Q., Sun Y., Hong Y., Rao H., Efe C., Lau G., Payawal D., Gani R., Lindor K., Jafri W., Omata M., Sarin S.K.
7407149871;57208572262;57200532284;57218488345;7404550067;57212924064;57216339526;7402950828;55531131800;56402234600;57188750283;8220686600;25122065500;36114075400;7801385732;23495930300;35418813000;23091123700;36043368300;57220191468;
The Asian Pacific Association for the Study of the Liver clinical practice guidance: the diagnosis and management of patients with autoimmune hepatitis
2021
Hepatology International
15
2
223
257
7
Peking University First Hospital, Beijing, China; Teikyo University School of Medicine, Tokyo, Japan; Beijing Friendship Hospital, Capital Medical University, Beijing, China; Shanghai Institute of Digestive Disease, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China; Department of Human Pathology, Kanazawa University Graduate School of Medicine Kanazawa, Kanazawa, Japan; Fifth Medical Center, Chinese PLA General Hospital, Beijing, China; Beijing Tsinghua Changgung Hospital, Beijing, China; Peking University People’s Hospital, Beijing, China; Department of Gastroenterology, Harran University, Şanlıurfa, Turkey; Humanity and Health Medical Group, Hong Kong; Department of Hepatology, Cardinal Santos Medical Center, Manila, Philippines; Department of Internal Medicine, Cipto Mangunkusumo Hospital, University of Indonesia, Jakarta, Indonesia; College of Health Solutions, Arizona State University, Phoenix, AZ, United States; Aga Khan University, Karachi, Pakistan; Department of Gastroenterology, Yamanashi Prefectural Central Hospital, Kofu-City, Yamanashi, Japan; The University of Tokyo, Tokyo, Japan; Institute of Liver and Biliary Sciences, New Delhi, India; Peking University International Hospital, Beijing, China
Wang, G., Peking University First Hospital, Beijing, China, Peking University International Hospital, Beijing, China; Tanaka, A., Teikyo University School of Medicine, Tokyo, Japan; Zhao, H., Peking University First Hospital, Beijing, China, Peking University International Hospital, Beijing, China; Jia, J., Beijing Friendship Hospital, Capital Medical University, Beijing, China; Ma, X., Shanghai Institute of Digestive Disease, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China; Harada, K., Department of Human Pathology, Kanazawa University Graduate School of Medicine Kanazawa, Kanazawa, Japan; Wang, F.-S., Fifth Medical Center, Chinese PLA General Hospital, Beijing, China; Wei, L., Beijing Tsinghua Changgung Hospital, Beijing, China; Wang, Q., Shanghai Institute of Digestive Disease, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China; Sun, Y., Fifth Medical Center, Chinese PLA General Hospital, Beijing, China; Hong, Y., Peking University First Hospital, Beijing, China; Rao, H., Peking University People’s Hospital, Beijing, China; Efe, C., Department of Gastroenterology, Harran University, Şanlıurfa, Turkey; Lau, G., Humanity and Health Medical Group, Hong Kong; Payawal, D., Department of Hepatology, Cardinal Santos Medical Center, Manila, Philippines; Gani, R., Department of Internal Medicine, Cipto Mangunkusumo Hospital, University of Indonesia, Jakarta, Indonesia; Lindor, K., College of Health Solutions, Arizona State University, Phoenix, AZ, United States; Jafri, W., Aga Khan University, Karachi, Pakistan; Omata, M., Department of Gastroenterology, Yamanashi Prefectural Central Hospital, Kofu-City, Yamanashi, Japan, The University of Tokyo, Tokyo, Japan; Sarin, S.K., Institute of Liver and Biliary Sciences, New Delhi, India
[No abstract available]
6 mercaptopurine derivative; azathioprine; budesonide; corticosteroid; cyclosporine; farnesoid X receptor; infliximab; mycophenolate mofetil; prednisone; rapamycin; tacrolimus; antibody detection; Asia; autoimmune hepatitis; autoimmunity; cataract; chronic liver disease; clinical practice; cytokine production; decompensated liver cirrhosis; diabetes mellitus; disease predisposition; drug efficacy; drug exposure; drug safety; dual energy X ray absorptiometry; environmental factor; gene locus; genetic susceptibility; geographic distribution; human; hypertension; immunoglobulin blood level; immunological tolerance; immunoregulation; incidence; liver biopsy; liver cell carcinoma; liver transplantation; magnetic resonance elastography; nonalcoholic fatty liver; Note; osteoporosis; Pacific islan
Springer
19360533
33942203
Note
Q2
1304
2874